India sulfadiazine market is expected to grow at a steady rate during the forecast period. The India sulfadiazine market is driven by the widespread use of the drug along with pyrimethamine for the treatment of toxoplasmosis. Additionally, the drug is used in the treatment of rheumatoid fever, chlamydia, among others. Furthermore, the drug is present in the WHO’s list of essential medications. This in turn is expected to positively influence the market growth through FY2026.
The India sulfadiazine market is segmented based on product type, route of administration, source, form, distribution channel, application, end user, company and region. Based on route of administration, the market can be categorized into oral, topical and intravenous. The oral route is expected to dominate the market since when the drug is consumed orally the absorption takes place along the complete line of GI tract.
The major players operating in the India sulfadiazine market are Abbott India Ltd., Boehringer Ingelheim India Private Ltd., Novartis India Ltd., Emcure Pharmaceuticals Ltd., Sun Pharmaceuticals Industries Ltd., Anuh Pharma Ltd., Anuja Healthcare Ltd., Salvi Chemical Industries Ltd., Centurion Laboratories Private Ltd., Pfizer Ltd. and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions, portfolio enhancement and new product developments.
Years considered for this report
Historical YearsFY2016-FY2019
Base YearFY2020
Estimated YearFY2021
Forecast PeriodFY2022–FY2026
Objective of the Study
- To analyze and estimate the market size of India sulfadiazine market from FY2016 to FY2019.
- To estimate and forecast the market size of India sulfadiazine market from FY2020 to FY2026 and growth rate until FY2026.
- To classify and forecast India sulfadiazine market based on product type, route of administration, source, form, distribution channel, application, end user, company and regional distribution.
- To identify dominant region or segment in the India sulfadiazine market.
- To identify drivers and challenges for India sulfadiazine market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India sulfadiazine market.
- To identify and analyze the profile of leading players operating in India sulfadiazine market.
- To identify key sustainable strategies adopted by market players in India sulfadiazine market.
Click here to download the sample
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.
TechSci Research calculated the market size of
Key Target Audience
- Sulfadiazine manufacturers/ suppliers/ distributors
- Market research and consulting firms
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to sulfadiazine
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
